Navigation Links
Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
Date:4/1/2008

cells and thereby prevent viral replication, which occurs within the cells. CCR5 is also a receptor for chemokines, members of a family of protein molecules that are secreted by cells as part of the body's natural inflammatory response. Unlike small- molecule CCR5 antagonists, PRO 140 inhibits HIV entry at concentrations that in vitro do not appear to block CCR5's natural function, which includes, in part, directing the migration of immune cells towards sites of inflammation in the body.

About Progenics Pharmaceuticals, Inc.

Progenics Pharmaceuticals, Inc., of Tarrytown, NY, is a biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Principal programs are directed toward gastroenterology as well as the treatment of HIV infection and cancer. The Company, in collaboration with Wyeth, is developing methylnaltrexone for the treatment of opioid-induced side effects, including constipation (oral and subcutaneous formulations) and post-operative ileus (intravenous formulation). In March 2007, the Company submitted a New Drug Application to the United States Food and Drug Administration for the subcutaneous formulation of methylnaltrexone for patients suffering from opioid-induced constipation while receiving palliative care, followed in May 2007 by Wyeth's submission of a Marketing Authorization Application (MAA) in Europe to the European Medicines Agency (EMEA). In the area of HIV infection, the Company is developing the viral-entry inhibitor PRO 140, a humanized monoclonal antibody targeting the HIV entry co-receptor CCR5, which has completed phase 1b clinical studies with positive results. In the area of prostate cancer, the Company is developing a human monoclonal antibody drug conjugate -- a selectively targeted cytotoxic antibody directed against prostate-specific membrane antigen (PSMA), a pro
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium
2. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
3. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
4. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
5. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
8. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
9. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
10. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
11. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014  NuView Life Sciences, Inc. (NuView) ... collaboration agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) ... diagnostic biomarker to detect cancers of the breast ... future diagnostic-imaging applications. NuView retains all rights for ... in-vitro urine screen applications. Under the ...
(Date:9/17/2014)... Calif. , Sept. 17, 2014 ... announced that it has earned a $4 million ... AKAO ) associated with the initiation of a ... serious multi-drug resistant (MDR), gram-negative bacterial infections.  The ... study to evaluate the efficacy and safety of ...
(Date:9/17/2014)...  Trovagene, Inc., (NASDAQ:   TROV) a developer of ... , Ph.D., has joined the Company,s Scientific Advisory Board. ... in the kinase genes that are associated with colorectal ... Department of Oncology, Torino Medical School, Institute for Cancer ... "Alberto,s work in cancer genomics has had ...
Breaking Medicine Technology:NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 2NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 3NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 4NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 5Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 2Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 3Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 2Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 3
... global provider of advanced analytical instruments for laboratories and ... MultiTek(TM) testing system for the fast, accurate detection of ... include BioFuels, Chemicals, Food & Beverage, Manufacturing and Assembly, ... is the only instrument on the market that combines ...
... personalized medicine advances will create therapies that are so effective, ... to gain access, the inventor of the DNA gene sequencer ... Personalized Health Care National Conference . , ... said personalized medicine,s first "killer apps" - therapies that will ...
Cached Medicine Technology:New ANTEK MultiTek(TM) by PAC Provides Fast, All-in-One Testing for Sulfur, Nitrogen, Halides 2Personalized Medicine 'Killer Apps' Will Transform Care Model 2
(Date:9/17/2014)... Dr. Shervin Naderi, MD, FACS, one of the ... recipient of the 2014 Vitals Top 10 Doctor Award. This ... as it honors physicians that have earned the highest patient ... by his plastic surgeon colleagues as “The Nose Man,” is ... surgeons in the world. He is the founder of ...
(Date:9/17/2014)... September 17, 2014 Promising new research ... sheds more light on the potential ability of ketones ... disease dementia. The study shows that ... be caused by impaired glucose uptake and/or utilization, and ... brain function. , The study, by the Research Center ...
(Date:9/17/2014)... 2014) A study led by St. Jude Children,s ... threshold below which male childhood cancer survivors are ... appears in September 17 edition of the journal ... patients are at highest risk for reduced sperm ... eventually increase use of pre-treatment fertility preservation methods ...
(Date:9/17/2014)... leads to an explosion of flavours in your mouth. Researchers ... can mimic what happens in your mouth when you drink ... dryness in the wine. , When wine growers turn their ... processes to bring out the desired flavour in the product ... of the taste is known in wine terminology as astringency, ...
(Date:9/17/2014)... Los Angeles, CA (PRWEB) September 17, 2014 ... Indian news outlet, tells of a 24-year-old man named Advait ... severe back pain caused by degenerative disc disease. This ... putting pressure on his nerve roots and causing severe ... degenerative disc disease and how it can lead to ...
Breaking Medicine News(10 mins):Health News:Vitals Honors Dr. Shervin Naderi With Top 10 Doctor Award 2Health News:Vitals Honors Dr. Shervin Naderi With Top 10 Doctor Award 3Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 2Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 3Health News:Improved risk identification will aid fertility preservation in young male cancer patients 2Health News:Improved risk identification will aid fertility preservation in young male cancer patients 3Health News:Nanoscience makes your wine better 2Health News:Nanoscience makes your wine better 3Health News:24-Year-Old Back in College After Degenerative Disc Disease Kept Him Out 2Health News:24-Year-Old Back in College After Degenerative Disc Disease Kept Him Out 3
... reactions to a,prescribed medication send more than 175,000 older ... used medications -- almost all,of them for heart disease ... March 2008 issue of the Harvard Heart Letter offers ... Warfarin: Check your bleeding time (INR) regularly. Take ...
... and Amortization Increased ... 3.85% and 2.96%, Respectively, MEXICO CITY, ... "the Group"), one of the leading Mexican,distributors of pharmaceutical products, ... other products,announces its consolidated financial and operating results for the ...
... is a,statement by William V. Corr, Executive Director, ... restaurants, bars and gaming,facilities, will be smoke-free beginning ... the Legislature last week and signed,into law today ... have delivered a historic victory for public health ...
... West announced today,that one of the country,s most iconic ... The Shops at The Bravern in downtown Bellevue as ... the needs of approximately 2,300,Microsoft employees who will be ... this fall., DavidBartonGym will offer Barton,s world renowned ...
... Over 200,of MemorialCare,s top leaders will participate in ... Habitat for Humanity of Orange County. The,home will be ... cerebral palsy and is confined to a wheelchair. Halls ... will be given a "makeover" with,upgrades throughout., (Photo: ...
... patient acceptance and ... ... that treats acute and chronic constipation, may be an,effective option for ... PEG 3350 products. Marketed in the,U.S. by Cumberland Pharmaceuticals, Kristalose(R) is ...
Cached Medicine News:Health News:Tips for Troublesome Medications, From the Harvard Heart Letter 2Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 2Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 3Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 4Health News:Nebraska's New Smoke-Free Law is Historic Win for Health 2Health News:World-Famous DavidBartonGym Buffs up the Bravern 2Health News:World-Famous DavidBartonGym Buffs up the Bravern 3Health News:MemorialCare Sponsors Habitat for Humanity Santa Ana Home 2Health News:Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products 2Health News:Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products 3
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: